Yan‐Jun Xiang
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer Mechanisms and Therapy
Papers in
- Hepatology 26
- Hepatocellular Carcinoma Treatment and Prognosis 26
- Liver physiology and pathology 2
- Surgery 13
- Cholangiocarcinoma and Gallbladder Cancer Studies 13
- Co-authors
- Yuqiang Cheng (15 shared papers)Kang Wang (16 shared papers)Hongming Yu (15 shared papers)Shuqun Cheng (15 shared papers)Wei‐Xing Guo (12 shared papers)Shuqun Cheng (14 shared papers)Liping Zhou (7 shared papers)Yingyi Qin (5 shared papers)
- Journals
- Frontiers in Oncology (4 papers)Hepatology International (3 papers)BMC Cancer (3 papers)Cancer Medicine (2 papers)Hepatology Research (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Yan‐Jun Xiang
28 papers receiving 299 citations
Hit Papers
Peers
Comparison fields: 5 of 41
- Hepatology 232
- Pathology and Forensic Medicine 72
- Oncology 88
- Cancer Research 35
- Epidemiology 78
Countries citing papers authored by Yan‐Jun Xiang
This map shows the geographic impact of Yan‐Jun Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan‐Jun Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan‐Jun Xiang more than expected).
Fields of papers citing papers by Yan‐Jun Xiang
This network shows the impact of papers produced by Yan‐Jun Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan‐Jun Xiang. The network helps show where Yan‐Jun Xiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan‐Jun Xiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial Hit paper breakdown → | 2024 | 64 |
| 2 | 2022 | 31 | |
| 3 | 2023 | 21 | |
| 4 | 2023 | 20 | |
| 5 | 2023 | 18 | |
| 6 | 2022 | 17 | |
| 7 | 2021 | 13 | |
| 8 | 2022 | 12 | |
| 9 | A study and analysis of the deaths due to advanced Schistosoma japonicum infection in the Dongting Lake area of China. | 1993 | 12 |
| 10 | 2023 | 11 | |
| 11 | 2022 | 11 | |
| 12 | 2022 | 10 | |
| 13 | 2023 | 6 | |
| 14 | 2023 | 6 | |
| 15 | 2023 | 6 | |
| 16 | 2024 | 5 | |
| 17 | 2023 | 5 | |
| 18 | 2024 | 4 | |
| 19 | 2023 | 4 | |
| 20 | 2022 | 4 |
About Yan‐Jun Xiang
Yan‐Jun Xiang is a scholar working on Hepatology, Surgery, Pathology and Forensic Medicine, Oncology and Epidemiology, having authored 32 papers that have together received 302 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (26 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers), Cancer Mechanisms and Therapy (10 papers), Liver Disease Diagnosis and Treatment (6 papers), Pancreatic and Hepatic Oncology Research (5 papers), Cancer, Lipids, and Metabolism (4 papers), Liver physiology and pathology (2 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Hepatology (232 citations), Pathology and Forensic Medicine (72 citations), Oncology (88 citations), Cancer Research (35 citations) and Epidemiology (78 citations). Yan‐Jun Xiang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yuqiang Cheng, Kang Wang, Hongming Yu, Shuqun Cheng, Wei‐Xing Guo, Shuqun Cheng, Liping Zhou, Yingyi Qin, Jie Shi and Wan Yee Lau. Their work appears in journals such as Frontiers in Oncology, Hepatology International, BMC Cancer, Cancer Medicine and Hepatology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.